Tumor-infiltrating lymphocytes and response to platinum in triple-negative breast cancer
- PMID: 25559817
- DOI: 10.1200/JCO.2014.59.6031
Tumor-infiltrating lymphocytes and response to platinum in triple-negative breast cancer
Comment on
-
Tumor-infiltrating lymphocytes and response to neoadjuvant chemotherapy with or without carboplatin in human epidermal growth factor receptor 2-positive and triple-negative primary breast cancers.J Clin Oncol. 2015 Mar 20;33(9):983-91. doi: 10.1200/JCO.2014.58.1967. Epub 2014 Dec 22. J Clin Oncol. 2015. PMID: 25534375 Clinical Trial.
Similar articles
-
Tumor-infiltrating lymphocytes and response to neoadjuvant chemotherapy with or without carboplatin in human epidermal growth factor receptor 2-positive and triple-negative primary breast cancers.J Clin Oncol. 2015 Mar 20;33(9):983-91. doi: 10.1200/JCO.2014.58.1967. Epub 2014 Dec 22. J Clin Oncol. 2015. PMID: 25534375 Clinical Trial.
-
Outcome for triple negative breast cancer in a retrospective cohort with an emphasis on response to platinum-based neoadjuvant therapy.Breast Cancer Res Treat. 2019 Feb;174(1):1-13. doi: 10.1007/s10549-018-5066-6. Epub 2018 Nov 28. Breast Cancer Res Treat. 2019. PMID: 30488345 Free PMC article.
-
Triple-Negative Breast Cancer: Who Should Receive Neoadjuvant Chemotherapy?Surg Oncol Clin N Am. 2018 Jan;27(1):141-153. doi: 10.1016/j.soc.2017.08.004. Surg Oncol Clin N Am. 2018. PMID: 29132557 Review.
-
Role of TP53 mutations in triple negative and HER2-positive breast cancer treated with neoadjuvant anthracycline/taxane-based chemotherapy.Oncotarget. 2016 Oct 18;7(42):67686-67698. doi: 10.18632/oncotarget.11891. Oncotarget. 2016. PMID: 27611952 Free PMC article.
-
A meta-analysis of platinum-based neoadjuvant chemotherapy versus standard neoadjuvant chemotherapy for triple-negative breast cancer.Future Oncol. 2019 Aug;15(23):2779-2790. doi: 10.2217/fon-2019-0165. Epub 2019 Jul 11. Future Oncol. 2019. PMID: 31293180
Cited by
-
Pharmacological Inhibition of Necroptosis Promotes Human Breast Cancer Cell Proliferation and Metastasis.Onco Targets Ther. 2020 Apr 16;13:3165-3176. doi: 10.2147/OTT.S246899. eCollection 2020. Onco Targets Ther. 2020. Retraction in: Onco Targets Ther. 2024 Jul 03;17:541-542. doi: 10.2147/OTT.S484569. PMID: 32368076 Free PMC article. Retracted.
-
Distribution and prognostic value of tumor‑infiltrating T cells in breast cancer.Mol Med Rep. 2018 Nov;18(5):4247-4258. doi: 10.3892/mmr.2018.9460. Epub 2018 Sep 5. Mol Med Rep. 2018. PMID: 30221739 Free PMC article.
-
Glutathione biosynthesis is a metabolic vulnerability in PI(3)K/Akt-driven breast cancer.Nat Cell Biol. 2016 May;18(5):572-8. doi: 10.1038/ncb3341. Epub 2016 Apr 18. Nat Cell Biol. 2016. PMID: 27088857 Free PMC article.
-
An immune stratification reveals a subset of PD-1/LAG-3 double-positive triple-negative breast cancers.Breast Cancer Res. 2016 Dec 3;18(1):121. doi: 10.1186/s13058-016-0783-4. Breast Cancer Res. 2016. PMID: 27912781 Free PMC article.
-
Standardized evaluation of tumor-infiltrating lymphocytes in breast cancer: results of the ring studies of the international immuno-oncology biomarker working group.Mod Pathol. 2016 Oct;29(10):1155-64. doi: 10.1038/modpathol.2016.109. Epub 2016 Jul 1. Mod Pathol. 2016. PMID: 27363491
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous